The AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenic stroke (ARCADIA) randomized trial: Rationale and Methods

RATIONALE: Recent data suggest that a thrombogenic atrial substrate can cause stroke in the absence of atrial fibrillation. Such an atrial cardiopathy may explain some proportion of cryptogenic strokes. AIMS: The aim of the ARCADIA trial is to test the hypothesis that apixaban is superior to aspirin...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Int J Stroke
Prif Awduron: Kamel, Hooman, Longstreth, W. T., Tirschwell, David L., Kronmal, Richard A., Broderick, Joseph P., Palesch, Yuko Y., Meinzer, Caitlyn, Dillon, Catherine, Ewing, Irene, Spilker, Judith A., Di Tullio, Marco R., Hod, Eldad A., Soliman, Elsayed Z., Chaturvedi, Seemant, Moy, Claudia S., Janis, Scott, Elkind, Mitchell S.V.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2018
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6645380/
https://ncbi.nlm.nih.gov/pubmed/30196789
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1747493018799981
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg